<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The German Thorotrast study comprises 2,326 patients and 1,890 controls </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-eight Thorotrast patients and 239 controls are still alive and are invited for a follow-up examination every 2 years </plain></SENT>
<SENT sid="2" pm="."><plain>In the deceased patients, the following <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">neoplastic diseases</z:e> with excess rates were registered (Thorotrast/controls): <z:hpo ids='HP_0002896'>liver cancer</z:hpo> (454/3); <z:e sem="disease" ids="C0740277" disease_type="Neoplastic Process" abbrv="">cancer of the bile ducts</z:e>, including gallbladder (42/7); myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (40/7); <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (30/4); <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> (10/2); non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (15/5); bone <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (4/1); malignant peritoneal or <z:hpo ids='HP_0100002'>pleural mesothelioma</z:hpo> (9/0) </plain></SENT>
<SENT sid="3" pm="."><plain>Dose calculations are based on results of whole-body counting, X-ray films, and data obtained from the hospital records on the volume of Thorotrast injected </plain></SENT>
<SENT sid="4" pm="."><plain>For <z:hpo ids='HP_0002896'>liver cancer</z:hpo>, the cumulative risk estimate was calculated to be 40 per 10(4) person Sv (radiation weighting factor = 20) </plain></SENT>
<SENT sid="5" pm="."><plain>These figures are close to the results of the Danish study and are comparable to the results of the Life Span Study of A-bomb survivors after 40 years at risk with 18 to 48 <z:hpo ids='HP_0002896'>liver cancers</z:hpo> per 10(4) person Sv </plain></SENT>
<SENT sid="6" pm="."><plain>For <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e>, the cumulative risk was calculated to be about 7 per 10(4) person Sv (radiation weighting factor = 20) </plain></SENT>
<SENT sid="7" pm="."><plain>This risk estimate is lower by a factor of 10 compared to the results of the Life Span Study </plain></SENT>
</text></document>